Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Semin Nucl Med

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    May 2018
  1. DONDI M, Paez D, Torres L, Marengo M, et al
    Implementation of Quality Systems in Nuclear Medicine: Why It Matters. An Outcome Analysis (Quality Management Audits in Nuclear Medicine Part III).
    Semin Nucl Med. 2018;48:299-306.
    PubMed     Text format     Abstract available


  2. PACILIO M, Lauri C, Prosperi D, Petitti A, et al
    New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
    Semin Nucl Med. 2018;48:261-276.
    PubMed     Text format     Abstract available


  3. SOLLINI M, Berchiolli R, Kirienko M, Rossi A, et al
    PET/MRI in Infection and Inflammation.
    Semin Nucl Med. 2018;48:225-241.
    PubMed     Text format     Abstract available


    March 2018
  4. SALMANOGLU E, Kim S, Thakur ML
    Currently Available Radiopharmaceuticals for Imaging Infection and the Holy Grail.
    Semin Nucl Med. 2018;48:86-99.
    PubMed     Text format     Abstract available


  5. ORDONEZ AA, Jain SK
    Pathogen-Specific Bacterial Imaging in Nuclear Medicine.
    Semin Nucl Med. 2018;48:182-194.
    PubMed     Text format     Abstract available


  6. KOUIJZER IJE, Mulders-Manders CM, Bleeker-Rovers CP, Oyen WJG, et al
    Fever of Unknown Origin: the Value of FDG-PET/CT.
    Semin Nucl Med. 2018;48:100-107.
    PubMed     Text format     Abstract available


    January 2018
  7. CHESON BD
    PET/CT in Lymphoma: Current Overview and Future Directions.
    Semin Nucl Med. 2018;48:76-81.
    PubMed     Text format     Abstract available


  8. SPECHT L, Berthelsen AK
    PET/CT in Radiation Therapy Planning.
    Semin Nucl Med. 2018;48:67-75.
    PubMed     Text format     Abstract available


  9. EL-GALALY TC, Gormsen LC, Hutchings M
    PET/CT for Staging; Past, Present, and Future.
    Semin Nucl Med. 2018;48:4-16.
    PubMed     Text format     Abstract available


  10. KARLS S, Shah H, Jacene H
    PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
    Semin Nucl Med. 2018;48:37-49.
    PubMed     Text format     Abstract available


  11. KOBE C, Dietlein M, Hellwig D
    PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma.
    Semin Nucl Med. 2018;48:28-36.
    PubMed     Text format     Abstract available


  12. GALLAMINI A, Zwarthoed C
    Interim FDG-PET Imaging in Lymphoma.
    Semin Nucl Med. 2018;48:17-27.
    PubMed     Text format     Abstract available


    November 2017
  13. DONDI M, Torres L, Marengo M, Massardo T, et al
    Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine Program. Part 2: Analysis of Results.
    Semin Nucl Med. 2017;47:687-693.
    PubMed     Text format     Abstract available


  14. DONDI M, Torres L, Marengo M, Massardo T, et al
    Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine (QUANUM) Program. Part 1: the QUANUM Program and Methodology.
    Semin Nucl Med. 2017;47:680-686.
    PubMed     Text format     Abstract available


  15. WALDMAN LE, Scharf SC
    Bone SPECT/CT of the Spine, Foot, and Ankle: Evaluation of Surgical Patients.
    Semin Nucl Med. 2017;47:639-646.
    PubMed     Text format     Abstract available


  16. PALESTRO CJ, Love C
    Role of Nuclear Medicine for Diagnosing Infection of Recently Implanted Lower Extremity Arthroplasties.
    Semin Nucl Med. 2017;47:630-638.
    PubMed     Text format     Abstract available


  17. GARG G, Benchekroun MT, Abraham T
    FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls.
    Semin Nucl Med. 2017;47:579-594.
    PubMed     Text format     Abstract available


    September 2017
  18. MATHIS CA, Lopresti BJ, Ikonomovic MD, Klunk WE, et al
    Small-molecule PET Tracers for Imaging Proteinopathies.
    Semin Nucl Med. 2017;47:553-575.
    PubMed     Text format     Abstract available


  19. KILBOURN MR
    Small Molecule PET Tracers for Transporter Imaging.
    Semin Nucl Med. 2017;47:536-552.
    PubMed     Text format     Abstract available


  20. MACH RH
    Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors.
    Semin Nucl Med. 2017;47:524-535.
    PubMed     Text format     Abstract available


  21. JACKSON IM, Scott PJH, Thompson S
    Clinical Applications of Radiolabeled Peptides for PET.
    Semin Nucl Med. 2017;47:493-523.
    PubMed     Text format     Abstract available


  22. SCHIRRMACHER R, Wangler B, Bailey J, Bernard-Gauthier V, et al
    Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers.
    Semin Nucl Med. 2017;47:474-492.
    PubMed     Text format     Abstract available


  23. DONNELLY DJ
    Small Molecule PET Tracers in Drug Discovery.
    Semin Nucl Med. 2017;47:454-460.
    PubMed     Text format     Abstract available


  24. VAVERE AL, Scott PJH
    Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook.
    Semin Nucl Med. 2017;47:429-453.
    PubMed     Text format     Abstract available


    July 2017
  25. KUBOTA K, Yamashita H, Mimori A
    Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.
    Semin Nucl Med. 2017;47:408-424.
    PubMed     Text format     Abstract available


  26. VAN DER BRUGGEN W, Glaudemans AWJM, Vellenga E, Slart RHJA, et al
    PET in Benign Bone Marrow Disorders.
    Semin Nucl Med. 2017;47:397-407.
    PubMed     Text format     Abstract available


  27. ROHREN EM, Macapinlac HA
    Spectrum of Benign Bone Conditions on NaF-PET.
    Semin Nucl Med. 2017;47:392-396.
    PubMed     Text format     Abstract available


  28. PARGHANE RV, Basu S
    Dual-time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations.
    Semin Nucl Med. 2017;47:373-391.
    PubMed     Text format     Abstract available


  29. PARIDA GK, Roy SG, Kumar R
    FDG-PET/CT in Skeletal Muscle: Pitfalls and Pathologies.
    Semin Nucl Med. 2017;47:362-372.
    PubMed     Text format     Abstract available


  30. METSER U, Tau N
    Benign Cutaneous and Subcutaneous Lesions on FDG-PET/CT.
    Semin Nucl Med. 2017;47:352-361.
    PubMed     Text format     Abstract available


  31. ADAMS HJA, Kwee TC
    Guest Editorial on PET of Benign Musculoskeletal Conditions.
    Semin Nucl Med. 2017;47:320-321.
    PubMed     Text format    


    May 2017
  32. PELLETIER-GALARNEAU M, Martineau P, Zuckier LS, Pham X, et al
    18F-FDG-PET/CT Imaging of Thoracic and Extrathoracic Tuberculosis in Children.
    Semin Nucl Med. 2017;47:304-318.
    PubMed     Text format     Abstract available


  33. SIGNORE A, Glaudemans AWJM, Gheysens O, Lauri C, et al
    Nuclear Medicine Imaging in Pediatric Infection or Chronic Inflammatory Diseases.
    Semin Nucl Med. 2017;47:286-303.
    PubMed     Text format     Abstract available


  34. PARISI MT, Bermo MS, Alessio AM, Sharp SE, et al
    Optimization of Pediatric PET/CT.
    Semin Nucl Med. 2017;47:258-274.
    PubMed     Text format     Abstract available


  35. KLUGE R, Kurch L, Georgi T, Metzger M, et al
    Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma.
    Semin Nucl Med. 2017;47:242-257.
    PubMed     Text format     Abstract available


  36. HARRISON DJ, Parisi MT, Shulkin BL
    The Role of 18F-FDG-PET/CT in Pediatric Sarcoma.
    Semin Nucl Med. 2017;47:229-241.
    PubMed     Text format     Abstract available


  37. MENDICHOVSZKY I, Solar BT, Smeulders N, Easty M, et al
    Nuclear Medicine in Pediatric Nephro-Urology: An Overview.
    Semin Nucl Med. 2017;47:204-228.
    PubMed     Text format     Abstract available


  38. DRUBACH LA
    Nuclear Medicine Techniques in Pediatric Bone Imaging.
    Semin Nucl Med. 2017;47:190-203.
    PubMed     Text format     Abstract available


  39. BAR-SEVER Z
    Scintigraphic Evaluation of Gastroesophageal Reflux and Pulmonary Aspiration in Children.
    Semin Nucl Med. 2017;47:275-285.
    PubMed     Text format     Abstract available


    March 2017
  40. MILANESI O, Stellin G, Zucchetta P
    Nuclear Medicine in Pediatric Cardiology.
    Semin Nucl Med. 2017;47:158-169.
    PubMed     Text format     Abstract available


  41. KELLER-PETROT I, Leger J, Sergent-Alaoui A, de Labriolle-Vaylet C, et al
    Congenital Hypothyroidism: Role of Nuclear Medicine.
    Semin Nucl Med. 2017;47:135-142.
    PubMed     Text format     Abstract available


  42. FAHEY FH, Goodkind AB, Plyku D, Khamwan K, et al
    Dose Estimation in Pediatric Nuclear Medicine.
    Semin Nucl Med. 2017;47:118-125.
    PubMed     Text format     Abstract available


  43. GELFAND MJ, Clements C, MacLean JR
    Nuclear Medicine Procedures in Children: Special Considerations.
    Semin Nucl Med. 2017;47:110-117.
    PubMed     Text format     Abstract available


  44. BIELSA IR
    Pediatric Nuclear Medicine and its Development as a Specialty.
    Semin Nucl Med. 2017;47:102-109.
    PubMed     Text format     Abstract available


  45. PFLUGER T, Piccardo A
    Neuroblastoma: MIBG Imaging and New Tracers.
    Semin Nucl Med. 2017;47:143-157.
    PubMed     Text format     Abstract available


    January 2017
  46. HERHOLZ K
    Brain Tumors: An Update on Clinical PET Research in Gliomas.
    Semin Nucl Med. 2017;47:5-17.
    PubMed     Text format     Abstract available


  47. THEODORE WH
    Presurgical Focus Localization in Epilepsy: PET and SPECT.
    Semin Nucl Med. 2017;47:44-53.
    PubMed     Text format     Abstract available


  48. GUNN RN, Rabiner EA
    Imaging in Central Nervous System Drug Discovery.
    Semin Nucl Med. 2017;47:89-98.
    PubMed     Text format     Abstract available


  49. TRIFILIEFF P, Ducrocq F, van der Veldt S, Martinez D, et al
    Blunted Dopamine Transmission in Addiction: Potential Mechanisms and Implications for Behavior.
    Semin Nucl Med. 2017;47:64-74.
    PubMed     Text format     Abstract available


  50. MALLIK A, Drzezga A, Minoshima S
    Clinical Amyloid Imaging.
    Semin Nucl Med. 2017;47:31-43.
    PubMed     Text format     Abstract available


    November 2016
  51. LINDENBERG L, Ahlman M, Turkbey B, Mena E, et al
    Advancement of MR and PET/MR in Prostate Cancer.
    Semin Nucl Med. 2016;46:536-543.
    PubMed     Text format     Abstract available


  52. BOUCHELOUCHE K, Turkbey B, Choyke PL
    PSMA PET and Radionuclide Therapy in Prostate Cancer.
    Semin Nucl Med. 2016;46:522-535.
    PubMed     Text format     Abstract available


  53. SCHUSTER DM, Nanni C, Fanti S
    PET Tracers Beyond FDG in Prostate Cancer.
    Semin Nucl Med. 2016;46:507-521.
    PubMed     Text format     Abstract available


  54. JADVAR H
    Is There Use for FDG-PET in Prostate Cancer?
    Semin Nucl Med. 2016;46:502-506.
    PubMed     Text format     Abstract available


  55. LANGSTEGER W, Rezaee A, Pirich C, Beheshti M, et al
    18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.
    Semin Nucl Med. 2016;46:491-501.
    PubMed     Text format     Abstract available


  56. JALILIAN AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, et al
    Erratum to "Evaluation of Osseous Metastasis in Bone Scintigraphy" [Semin Nucl Med 46 (2016) 340-358].
    Semin Nucl Med. 2016;46:481.
    PubMed     Text format    


    September 2016
  57. HOFMAN MS, Hicks RJ
    Gallium-68 EDTA PET/CT for Renal Imaging.
    Semin Nucl Med. 2016;46:448-61.
    PubMed     Text format     Abstract available


  58. VORSTER M, Maes A, Wiele Cv, Sathekge M, et al
    Gallium-68 PET: A Powerful Generator-based Alternative to Infection and Inflammation Imaging.
    Semin Nucl Med. 2016;46:436-47.
    PubMed     Text format     Abstract available


  59. BAILEY DL, Eslick EM, Schembri GP, Roach PJ, et al
    (68)Ga PET Ventilation and Perfusion Lung Imaging-Current Status and Future Challenges.
    Semin Nucl Med. 2016;46:428-35.
    PubMed     Text format     Abstract available


  60. EO JS, Jeong JM
    Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Implications.
    Semin Nucl Med. 2016;46:419-27.
    PubMed     Text format     Abstract available


  61. KRATOCHWIL C, Afshar-Oromieh A, Kopka K, Haberkorn U, et al
    Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.
    Semin Nucl Med. 2016;46:405-18.
    PubMed     Text format     Abstract available


    July 2016
  62. ELGAZZAR AH, Owunwanne A, Alenezi S
    Structure and Activities of Nuclear Medicine in Kuwait.
    Semin Nucl Med. 2016;46:359-67.
    PubMed     Text format     Abstract available


  63. JALILIAN AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, et al
    Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
    Semin Nucl Med. 2016;46:340-58.
    PubMed     Text format     Abstract available


  64. KIRATLI PO, Tuncel M, Bar-Sever Z
    Nuclear Medicine in Pediatric and Adolescent Tumors.
    Semin Nucl Med. 2016;46:308-23.
    PubMed     Text format     Abstract available


  65. ERGUN EL, Saygi S, Yalnizoglu D, Oguz KK, et al
    SPECT-PET in Epilepsy and Clinical Approach in Evaluation.
    Semin Nucl Med. 2016;46:294-307.
    PubMed     Text format     Abstract available


  66. PAEZ D, Becic T, Bhonsle U, Jalilian AR, et al
    Current Status of Nuclear Medicine Practice in the Middle East.
    Semin Nucl Med. 2016;46:265-72.
    PubMed     Text format     Abstract available


    May 2016
  67. FREEMAN LM, Blaufox MD
    Letter From the Editors.
    Semin Nucl Med. 2016;46:181.
    PubMed     Text format    


    March 2016
  68. MOADEL RM
    Letter From the Guest Editor.
    Semin Nucl Med. 2016;46:98.
    PubMed     Text format    


  69. FREEMAN LM, Blaufox MD
    Letter From the Editors.
    Semin Nucl Med. 2016;46:97.
    PubMed     Text format    


    January 2016
  70. AREVALO-PEREZ J, Paris M, Graham MM, Osborne JR, et al
    A Perspective of the Future of Nuclear Medicine Training and Certification.
    Semin Nucl Med. 2016;46:88-96.
    PubMed     Text format     Abstract available


  71. EISENMENGER LB, Huo EJ, Hoffman JM, Minoshima S, et al
    Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.
    Semin Nucl Med. 2016;46:57-87.
    PubMed     Text format     Abstract available


  72. PLACZEK MS, Zhao W, Wey HY, Morin TM, et al
    PET Neurochemical Imaging Modes.
    Semin Nucl Med. 2016;46:20-7.
    PubMed     Text format     Abstract available


  73. SLOMKA PJ, Pan T, Germano G
    Recent Advances and Future Progress in PET Instrumentation.
    Semin Nucl Med. 2016;46:5-19.
    PubMed     Text format     Abstract available


  74. DI GIALLEONARDO V, Wilson DM, Keshari KR
    The Potential of Metabolic Imaging.
    Semin Nucl Med. 2016;46:28-39.
    PubMed     Text format     Abstract available


  75. OSBORNE JR
    Guest Editorial.
    Semin Nucl Med. 2016;46:3-4.
    PubMed     Text format    


  76. FREEMAN LM, Blaufox MD
    Letter from the Editors.
    Semin Nucl Med. 2016;46:1-2.
    PubMed     Text format    


    July 2015
  77. FREEMAN L, Blaufox MD
    The potential application of PET/MRI to clinical Nuclear Medicine.
    Semin Nucl Med. 2015;45:267.
    PubMed     Text format    


    May 2015
  78. VON SCHULTHESS GK, Veit-Haibach P
    Guest editorial.
    Semin Nucl Med. 2015;45:189-91.
    PubMed     Text format    


  79. FREEMAN LM, Blaufox MD
    Editorial.
    Semin Nucl Med. 2015;45:187-8.
    PubMed     Text format    


    March 2015
  80. CARLIN S, Humm J
    Hypoxia imaging. Guest editorial.
    Semin Nucl Med. 2015;45:98-100.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: